4//SEC Filing
Kirk Sean 4
Accession 0001367644-20-000033
CIK 0001367644other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 8:19 PM ET
Size
14.8 KB
Accession
0001367644-20-000033
Insider Transaction Report
Form 4
Kirk Sean
EVP, Manufacturing & Tech Ops
Transactions
- Sale
Common Stock
2020-04-06$60.00/sh−5,666$339,960→ 12,571 total - Exercise/Conversion
Common Stock
2020-04-06$30.63/sh+7,293$223,385→ 19,864 total - Sale
Common Stock
2020-04-06$60.00/sh−7,293$437,580→ 12,571 total - Exercise/Conversion
Common Stock
2020-04-06$30.86/sh+3,135$96,746→ 15,706 total - Sale
Common Stock
2020-04-06$60.00/sh−3,135$188,100→ 12,571 total - Sale
Employee Stock Options (Right to Buy)
2020-04-06$60.00/sh−3,135$188,100→ 38,805 totalExercise: $30.86Exp: 2021-02-28→ Employee Stock Options (Right to Buy) (3,135 underlying) - Sale
Employee Stock Options (Right to Buy)
2020-04-06$60.00/sh−7,293$437,580→ 31,512 totalExercise: $30.63Exp: 2022-02-27→ Employee Stock Options (Right to Buy) (7,293 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirk.
- [F2]Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated.
- [F3]The options vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeother
Related Parties
1- filerCIK 0001778426
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 8:19 PM ET
- Size
- 14.8 KB